The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion-Reference-Cited by-同舟云学术

The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion

Published:2019-01-29 Issue:3 Volume:38 Page:1005-1008
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Digesu Giuseppe Alessandro¹^ORCID,Tailor Visha¹,Preti Mario²,Vieira‐Baptista Pedro³⁴,Tarcan Tufan⁵,Stockdale Colleen⁶,Mourad Sherif⁷

Affiliation:

1. Imperial College HealthcareDepartment of UrogynaecologyLondonUK

2. Department of Obstetrics and GynecologyUniversity of TorinoTorinoItaly

3. Hospital Lusíadas PortoPortoPortugal

4. Lower Genital Tract UnitCentro Hospitalar de São JoãoPortoPortugal

5. Marmara University School of MedicineDepartment of UrologyIstanbulTurkey

6. Department of Obstetrics and GynecologyUniversity of IowaIowa CityIowa

7. Ain Shams UniversityDepartment of UrologyCairoEgypt

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.23927

Reference29 articles.

1. U.S. Food and Drug Administration. 510(k) Summary for RevLite Q‐Switched Nd:YAG Laser System [letter]. Silver Spring (MD): FDA; 2014. Available at:http://www.accessdata.fda.gov/cdrh_docs/pdf13/k133254.pdf. Retrieved May 19 2016.

2. ACOG Committee Opinion No. 378: Vaginal “Rejuvenation” and Cosmetic Vaginal Procedures

3. FDA Warns Against Use of Energy‐Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures: FDA Safety Communication.https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm615013.htm.

4. Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause

5. U.S. Food and Drug Administration. Re: trade/device name: DEKA SmartXide2 Laser System [letter]. Silver Spring (MD): FDA; 2014. Available at:http://www.accessdata.fda.gov/cdrh_docs/pdf13/k133895.pdf. Retrieved May 19 2016.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of women with vaginal laxity: systematic review with meta-analysis;The Journal of Sexual Medicine;2024-03-20

2. Cosmetic gynaecology;The Obstetrician & Gynaecologist;2023-12-11

3. Fractional CO2 laser treatment for women with stress predominant urinary incontinence: a randomized controlled trial;International Urogynecology Journal;2023-10-03

4. Research on evolution process of full‐layer incision of skin tissue under different laser incidences;Journal of Biophotonics;2023-09-24

5. Enhanced Recovery After Surgery (ERAS) Protocol on Urogynecological Surgeries: 3 years of follow-up after implementation;2023-01-11